Free Trial
LON:MANO

Manolete Partners (MANO) Share Price, News & Analysis

Manolete Partners logo

About Manolete Partners Stock (LON:MANO)

Key Stats

Today's Range
N/A
50-Day Range
95
148
52-Week Range
N/A
Volume
117,243 shs
Average Volume
21,932 shs
Market Capitalization
£46.92 million
P/E Ratio
5,350.00
Dividend Yield
0.37%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Manolete Partners Plc operates as an insolvency litigation financing company in the United Kingdom. It is involved in the acquisition and funding of insolvency litigation cases. Manolete Partners Plc was founded in 2009 and is headquartered in London, the United Kingdom.

Receive MANO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Manolete Partners and its competitors with MarketBeat's FREE daily newsletter.

MANO Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines

MANO Stock Analysis - Frequently Asked Questions

Manolete Partners Plc (LON:MANO) posted its quarterly earnings results on Thursday, November, 21st. The company reported $7.90 earnings per share for the quarter. Manolete Partners had a net margin of 3.55% and a trailing twelve-month return on equity of 2.34%.

Shares of MANO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Manolete Partners investors own include Advanced Oncotherapy (AVO), IQE (IQE), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR) and Greencore Group (GNC).

Company Calendar

Last Earnings
11/21/2019
Today
11/02/2024

Industry, Sector and Symbol

Industry
Consulting Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Net Income
£1.94 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.30 million
Book Value
GBX 93 per share

Miscellaneous

Free Float
N/A
Market Cap
£46.92 million
Optionable
Not Optionable
Beta
0.77
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (LON:MANO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners